3M Earnings Reports

3M reported Q4 sales of $6.0 billion, a 0.1% increase year-over-year, and adjusted sales of $5.8 billion with organic growth up 2.1%. GAAP EPS from continuing operations was $1.33, up 17% year-over-year, while adjusted EPS from continuing operations was $1.68, down 2%. The company initiated full-year 2025 financial guidance, projecting adjusted total sales growth of 0.5 to 1.5 percent and adjusted EPS in the range of $7.60 to $7.90.

3M reported Q3 2024 results with sales of $6.3 billion, up 0.4% YoY. GAAP EPS from continuing operations was $2.48, up 154% YoY, and adjusted EPS was $1.98, up 18% YoY. The company is updating its full-year 2024 adjusted EPS guidance to $7.20 to $7.30.

3M reported sales of $6.3 billion, a slight decrease of 0.5% year-over-year. GAAP EPS from continuing operations was $2.17, up 117% year-over-year, and adjusted EPS from continuing operations was $1.93, up 39% year-over-year. The company updated its full-year 2024 adjusted EPS guidance to $7.00 to $7.30.

3M delivered better-than-expected results in Q1 2024, returning to organic growth and achieving double-digit adjusted earnings growth. The company completed the spin-off of Solventum and finalized major legal settlements, positioning it for long-term shareholder value creation.

3M reported a decrease in sales by 0.8 percent year-on-year, with sales of $8.0 billion. GAAP earnings per share was $1.70, and adjusted EPS was $2.42, up 11 percent year-on-year. The company's operating cash flow was $2.0 billion, up 3 percent year-on-year, and adjusted free cash flow was $2.0 billion, up 18 percent year-on-year.

3M reported Q3 2023 results, highlighting strong operational execution, restructuring actions, and proactive spending discipline. The company is progressing with the Health Care spin-off, expected to be completed in the first half of 2024, and addressing legal matters with the Combat Arms settlement and preliminary court approval for the PFAS Public Water Systems agreement.

3M reported Q2 2023 results with sales of $8.3 billion, down 4.3 percent year-on-year, and an organic sales decline of 2.2 percent. GAAP loss per share was $12.35, including a $14.19 negative impact from the PWS settlement. Adjusted EPS was $2.17. The company raised its full-year adjusted EPS expectations for 2023 to $8.60 to $9.10.

3M reported a decrease in sales and earnings per share for the first quarter of 2023, but operating cash flow increased. The company announced restructuring actions expected to yield $700 to $900 million in annual pre-tax savings.

3M reported Q4 2022 results with sales of $8.1 billion, a decrease of 6 percent year-on-year. Organic sales growth was 0.4 percent. The company reported GAAP earnings per share of $0.98 and adjusted earnings per share of $2.28.

3M reported Q3 2022 results with GAAP earnings per share of $6.77 and adjusted earnings per share of $2.69. Sales were $8.6 billion, down 4 percent year-on-year, impacted by divestitures and foreign currency translation. Organic sales growth was 2 percent, including a headwind from declining respirator demand. The company updated its full-year sales and earnings expectations to reflect the strengthening U.S. dollar and the uncertain macroeconomic environment.

3M reported second-quarter 2022 results with adjusted earnings per share of $2.48. Sales were $8.7 billion, down 3 percent year-on-year. The company updated its adjusted full-year expectations largely due to the strength of the U.S. dollar and uncertain macroeconomic environment.

3M reported a slight decrease in sales but showed organic sales growth. GAAP earnings per share decreased, but adjusted earnings per share also saw a decline. The company continues to manage supply chain and inflationary challenges while investing in long-term growth and returning cash to shareholders.

3M delivered a solid fourth-quarter performance with sales of $8.6 billion, up 0.3 percent year-on-year, and earnings per share of $2.31. The company effectively managed supply chain disruptions, made progress on pricing actions, and controlled costs.

3M reported strong Q3 2021 results with sales of $8.9 billion, a 7.1% increase year-on-year. Organic local-currency sales grew by 6.3%. The company reported earnings per share of $2.45 and generated $1.5 billion in adjusted free cash flow.

3M reported strong second-quarter results with sales growing 24.7% year-on-year to $8.9 billion. Both GAAP and adjusted earnings were $2.59 per share. Second quarter operating income was $2.0 billion. The company updated its guidance for full-year 2021.

3M reported a strong first quarter with sales growing by 9.6% year-on-year to $8.9 billion and both GAAP and adjusted earnings were $2.77 per share, resulting in year-on-year increases of 23 percent and 27 percent, respectively.

3M reported a strong fourth quarter with year-on-year growth across all business segments and geographic areas. Sales grew 5.8 percent to $8.6 billion, and both GAAP and adjusted earnings were $2.38 per share.

3M reported Q3 2020 results with sales growing 4.5 percent year-on-year to $8.4 billion. Organic local-currency sales grew 0.9 percent. Both GAAP and adjusted earnings were $2.43 per share. Operating income was $1.9 billion with operating margins of 22.9 percent. The company’s operating cash flow was $2.5 billion with adjusted free cash flow of $2.2 billion.

3M's second-quarter results were significantly impacted by the global economic slowdown. The company executed well, managed costs, and delivered robust cash flow. Sales declined 12.2 percent year-on-year to $7.2 billion.

3M reported a sales increase of 2.7% to $8.1 billion. The company experienced strong growth in personal safety, home improvement, general cleaning, food safety and biopharma filtration. GAAP earnings were $2.22 per share, up 47% year-on-year.

3M reported fourth-quarter results with sales growing 2.1 percent year-on-year to $8.1 billion. Fourth-quarter GAAP earnings were $1.66 per share, a decrease of 27 percent year-on-year.